Growing cases of Atrial Fibrillation in aged people is the market fostering factor

The research report "Atrial Fibrillation Market: By Procedure (Pharmacological Drugs, Non-Pharmacological Treatments, Radiofrequency, HIFU, Cryoablation, Microwave, Laser, Catheter Ablation, Maze Surgery, Electric Cardioversion) By End User (Hospitals, Cardiac Clinics, Home Care), By Geography-Global/Region/Country Forecast to 2027", The Global Atrial Fibrillation Market was valued at USD 15445 Million in the year 2020 and is expected to grow at USD 43653 Million till 2027 recording a CAGR of 16% for the forecast period 2021-2027.

Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on " Atrial Fibrillation Market: By Procedure (Pharmacological Drugs, Non-Pharmacological Treatments, Radiofrequency, HIFU, Cryoablation, Microwave, Laser, Catheter Ablation, Maze Surgery, Electric Cardioversion) By End User (Hospitals, Cardiac Clinics, Home Care), By Geography-Global/Region/Country Forecast to 2027".

View detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-atrial-fibrillation-market/

The Atrial Fibrillation –Causes and Treatment options

The Atrial Fibrillation is the most common condition of arrhythmia. It causes due to mitral stenosis, obesity, pulmonary embolus, hyperthyroidism and cardiovascular illnesses. The most common symptoms of atrial fibrillation are palpitations, chest pain and fainting. Severity of the condition divides atrial fibrillation into three types such as paroxysmal, permanent and persistent. Patient suffering from atrial fibrillation can get the problem of blood clot forming in the heart. The common method to treat atrial fibrillation is use of medications, which slow down the heart rate to bring to normal sinus rhythm. Patient can also suffer from stroke problem due to atrial fibrillation. Blood-thinning and anti-clotting medicines are used to prevent the danger stroke occurrence and blood clot formation. Chronic AF can create the risk of death. In order to put off the recurrent condition, surgical cardiac ablation is suggested using catheter-based methods. Electrical cardioversions synchronized with sinoatrial node is also used to prevent the recurrence.

Conditions like hypertension, obesity and diabetes can lead to the cardiac disorders. People suffering from valvular and hypertension coronary sickness because of rheumatic fever can lead to atrial fibrillation. Growing cases of atrial fibrillation especially amid aged people is the major driving factor for market growth. A few of the other significant factors lead to the market growth are increasing need for minimally invasive methods, rapid post-surgical recovery times and small cardiac incision. On the other hand, high R&D expenses and the high medication expenses can hinder the growth of the atrial fibrillation market.

Request a case study or sample research report at https://precisionbusinessinsights.com/request-sample?product_id=25131

Impact of COVID-19 Atrial Fibrillation Market:

In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years.

Geographical Analysis:

Atrial fibrillation market is categorized into different prominent regions on the basis of region such as Africa, The Middle East, Latin America, North America and Europe. North America accounted for huge market revenue share in 2014 owing to the factor such as growing adoption of high advanced technologies in the countries of this region such as Mexico, U.S and Canada and the availability of refined healthcare infrastructure. Furthermore, Asia Pacific is anticipated to record huge gains during the forecast years because of the huge population and different age groups have the chances of suffering from cardiac illnesses. Demand for AF devices is anticipated to drive in the region because of the advancement in healthcare infrastructure.

Competitive Analysis:

A few major market participants operating in the market are Pfizer, Inc. (U.S.), Sanofi (France), Boehringer Ingelheim (Germany), Novartis (Switzerland), GlaxoSmithKline plc (U.K.), Bristol-Myers Squibb (U.S.), and Teva Pharmaceutical Industries Ltd. (Israel).

Contact Us:

Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:

We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.